Unresectable Malignant Gastrointestinal Stromal Tumor

Explore clinical trials studying Unresectable Malignant Gastrointestinal Stromal Tumor. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Unresectable Malignant Gastrointestinal Stromal Tumor trial results

Not Yet Recruiting

Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors

NCT07647068

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +11 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

NCT02500797

Conditions: Bone Diseases, Bone Neoplasms, Histiocytoma, +32 more
Locations: Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

Alaska Oncology and Hematology LLC Anchorage, Alaska, United States

View all 651 locations

View Trial Details

Unresectable Malignant Gastrointestinal Stromal Tumor

Unresectable Malignant Gastrointestinal Stromal Tumor trial results

Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

Related conditions